File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Structure-activity relationships (SAR) research of thiourea derivatives as dual inhibitors targeting both HIV-1 capsid and human cyclophilin A

TitleStructure-activity relationships (SAR) research of thiourea derivatives as dual inhibitors targeting both HIV-1 capsid and human cyclophilin A
Authors
KeywordsHIV-1
Thiourea derivatives
Human cyclophilin A
SAR
Capsid
Issue Date2010
Citation
Chemical Biology and Drug Design, 2010, v. 76, n. 1, p. 25-33 How to Cite?
AbstractHIV-1 capsid (CA) and human cyclophilin A (CypA) play important roles in HIV-1 assembly and disassembly processes, which are critical in HIV-1 replication. Based on the discovery of thiourea derivatives targeting both of the two proteins and indicating effective inhibitory activities in our group, we designed and synthesized a new class of thiourea derivatives. Their abilities to bind to capsid and cyclophilin A were determined by ultraviolet spectroscopic analysis, fluorescence binding affinity, and PPIase inhibition assay. Furthermore, the newly synthesized compounds were tested for their antiviral activities and cytotoxicities using CEM cells. According to the biological evaluation and subsequent molecular docking analyses, we studied the structure-activity relationships of thiourea derivatives. Three optimal compounds (K17, K24, K25) based on the achieved structure-activity relationships would be the basis for future optimization. © 2010 John Wiley & Sons A/S.
Persistent Identifierhttp://hdl.handle.net/10722/300164
ISSN
2020 Impact Factor: 2.817
2020 SCImago Journal Rankings: 0.590

 

DC FieldValueLanguage
dc.contributor.authorChen, Kan-
dc.contributor.authorTan, Zhiwu-
dc.contributor.authorHe, Meizi-
dc.contributor.authorLi, Jiebo-
dc.contributor.authorTang, Shixing-
dc.contributor.authorHewlett, Indira-
dc.contributor.authorYu, Fei-
dc.contributor.authorJin, Yinxue-
dc.contributor.authorYang, Ming-
dc.date.accessioned2021-06-04T05:49:11Z-
dc.date.available2021-06-04T05:49:11Z-
dc.date.issued2010-
dc.identifier.citationChemical Biology and Drug Design, 2010, v. 76, n. 1, p. 25-33-
dc.identifier.issn1747-0277-
dc.identifier.urihttp://hdl.handle.net/10722/300164-
dc.description.abstractHIV-1 capsid (CA) and human cyclophilin A (CypA) play important roles in HIV-1 assembly and disassembly processes, which are critical in HIV-1 replication. Based on the discovery of thiourea derivatives targeting both of the two proteins and indicating effective inhibitory activities in our group, we designed and synthesized a new class of thiourea derivatives. Their abilities to bind to capsid and cyclophilin A were determined by ultraviolet spectroscopic analysis, fluorescence binding affinity, and PPIase inhibition assay. Furthermore, the newly synthesized compounds were tested for their antiviral activities and cytotoxicities using CEM cells. According to the biological evaluation and subsequent molecular docking analyses, we studied the structure-activity relationships of thiourea derivatives. Three optimal compounds (K17, K24, K25) based on the achieved structure-activity relationships would be the basis for future optimization. © 2010 John Wiley & Sons A/S.-
dc.languageeng-
dc.relation.ispartofChemical Biology and Drug Design-
dc.subjectHIV-1-
dc.subjectThiourea derivatives-
dc.subjectHuman cyclophilin A-
dc.subjectSAR-
dc.subjectCapsid-
dc.titleStructure-activity relationships (SAR) research of thiourea derivatives as dual inhibitors targeting both HIV-1 capsid and human cyclophilin A-
dc.typeArticle-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1111/j.1747-0285.2010.00981.x-
dc.identifier.pmid20456372-
dc.identifier.scopuseid_2-s2.0-77952965850-
dc.identifier.volume76-
dc.identifier.issue1-
dc.identifier.spage25-
dc.identifier.epage33-
dc.identifier.eissn1747-0285-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats